SENATE BILL REPORT
SB 5022
As of February 2, 2023
Title: An act relating to exempting fentanyl testing equipment from the definition of drug paraphernalia.
Brief Description: Exempting fentanyl testing equipment from the definition of drug paraphernalia.
Sponsors: Senators Muzzall, Cleveland, Dhingra, Gildon, Hunt, Keiser, Kuderer, Mullet, Nobles, Van De Wege, Wilson, J. and Wilson, L..
Brief History:
Committee Activity: Law & Justice: 2/06/23.
Brief Summary of Bill
  • Excludes fentanyl testing equipment from the definition of drug paraphernalia.
SENATE COMMITTEE ON LAW & JUSTICE
Staff: Ryan Giannini (786-7285)
Background:

Drug Paraphernalia. Drug paraphernalia includes testing equipment used, intended for use, or designed for use in identifying or analyzing the strength, effectiveness, or purity of controlled substances.
 
It is unlawful under certain circumstances to use, possess, manufacture, deliver, give, sell, or advertise the sale of drug paraphernalia. Violators can be subject to civil or criminal liability.
 
Fentanyl. Fentanyl is a synthetic opioid. It is a Schedule II prescription drug, and it is typically used to treat patients with severe pain or to manage pain after surgery.
 
Illicitly manufactured fentanyl is available in different forms, including liquid and powder. Powdered fentanyl may be mixed with other drugs and made into pills that are made to resemble other prescription opioids.
 
Fentanyl test strips are a form of drug testing technology that can detect the presence of fentanyl in different kinds of drugs and drug forms.
Summary of Bill:

Fentanyl testing equipment is excluded from the definition of drug paraphernalia.
Appropriation: None.
Fiscal Note: Not requested.
Creates Committee/Commission/Task Force that includes Legislative members: No.
Effective Date: Ninety days after adjournment of session in which bill is passed.